Dr. Kimryn Rathmell

W. Kimryn Rathmell, MD, PhD, is a medical oncologist specializing in genitourinary oncology. She serves as Chief Executive Officer of The Ohio State University James Cancer Hospital and Solove Research Institute, where she holds the Jeri B. Block and Robert H. Schottenstein Distinguished Chair in Cancer. Clinically, Dr. Rathmell focuses on genitourinary oncology, hereditary and familial cancer management, and precision oncology. Her research centers on cancer genomics, tumor signaling and metabolism, and the translational development of biomarker-guided therapies. She is the former director of the National Cancer Institute and has held leadership roles in national organizations, including serving as president of the American Society for Clinical Investigation. Her honors include the American Cancer Society Medal of Honor, the ASCI Korsmeyer Award, and ASCO’s Women Who Conquer Cancer Award, and she is an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the Association of American Physicians. Dr. Rathmell earned her MD and PhD in biophysics from Stanford University, completed residency in internal medicine and a fellowship in medical oncology at the University of Pennsylvania.